Investors Research Corp Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$1.31M |
| 2 |
ACET
Aceto Corp
ACET
|
+$938K |
| 3 |
WPP
WPP
|
+$916K |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$885K |
| 5 |
Ceco Environmental
CECO
|
+$821K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cabot Corp
CBT
|
+$1.1M |
| 2 |
POT
Potash Corp Of Saskatchewan
POT
|
+$1.02M |
| 3 |
CPN
Calpine Corporation
CPN
|
+$969K |
| 4 |
CCC
Calgon Carbon Corp
CCC
|
+$831K |
| 5 |
Wolfspeed
WOLF
|
+$534K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.89% |
| 2 | Consumer Discretionary | 16.68% |
| 3 | Technology | 12.62% |
| 4 | Materials | 9.04% |
| 5 | Consumer Staples | 7.26% |
Similar funds
Investors Research Corp's Q1 2018 Portfolio in Review
As of Q1 2018, Investors Research Corp held 357 positions worth $164M, up 1.7% from $162M the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Investors Research Corp deployed $7.99M of net new capital in Q1 2018, opening 26 new positions and adding to 53 existing holdings. Its largest new stake was Nutrien: 26,205 shares worth $1.24M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was DIPLOMAT PHARMACY, INC., an estimated $60.7K trimmed.
- Investors Research Corp's largest Q1 2018 buy was Nutrien: 26,205 shares worth $1.24M.
- Investors Research Corp added most to Aceto Corp in Q1 2018, an estimated $938K increase.
- Investors Research Corp's biggest Q1 2018 reduction was DIPLOMAT PHARMACY, INC., cutting an estimated $60.7K.
- Investors Research Corp fully exited Cabot Corp in Q1 2018, selling an estimated $1.1M.
- Investors Research Corp's ten largest holdings make up 9.6% of its $164M portfolio in Q1 2018.
- Investors Research Corp opened 26 new positions and closed 19 in Q1 2018.
- Investors Research Corp's portfolio value rose 1.7% quarter-over-quarter to $164M.
Based on Investors Research Corp's 13F filing for Q1 2018, filed 9 May 2018.